Novum provides a full spectrum of services in managing multicenter Clinical Endpoint Studies and in conducting Early Phase Studies in our Novum Clinical Pharmacology Units.

Novum’s Early Phase CPUs and Clinical Trial Management Division provide turnkey services for the drug development programs of our sponsors. Our experience with complex products has supported NDA, 505(b)(2), ANDA and EU submissions.

Trust 40-plus years of industry experience as a full-service CRO, Novum has long-standing relationships with a range of global sponsors who rely on our Early Phase Research and Clinical Trial Management expertise to conduct more than 200 studies annually. By applying scientific acumen to each step of every study and maintaining the highest quality and safety standards, Novum has established a proven track record spanning more than 40 years serving diverse sponsors of all sizes. Our Early Phase Research and Clinical Trial Management divisions deliver results vital to the successful drug development programs of clients worldwide.

Novum’s full-service offerings provide a hassle-free, turnkey solution for your drug development programs. Guided by a senior management team with expertise in pharmacology, pharmacokinetics, statistical analysis, clinical operations, medical affairs and project management. Novum offers the highest levels of service, integrity, reliability and quality.